Associated risk factors for abnormal ankle-brachial index in hemodialysis patients in a hospital

Kaohsiung Journal of Medical Sciences

Volumn 24, Issue 9, 2008, Pages 473-480

  Chen, Szu Chia ^a   Su, Ho Ming ^a,c   Mai, Hsiu Chin ^a   Chen, Jui Hsin ^a   Chen, Chiu Yueh ^a   Chang, Jer Ming ^a,c   Chen, Hung Chun ^b,c  

^a KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Ankle brachial index; Hemodialysis; Peripheral artery disease

Indexed keywords

ALBUMIN;

ADULT; AGED; AGING; ALBUMIN BLOOD LEVEL; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEMATOCRIT; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PULSE PRESSURE; RISK ASSESSMENT; RISK FACTOR;

EID: 59149097457     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1607-551X(09)70004-X     Document Type: Article

References (38)

1. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000;35:S117-31.
2. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003;42:1050-65.
3. O'Hare A, Johansen K. Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol 2001;12:2838-47.
4. Fishbane S, Youn S, Kowalski EJ, et al. Ankle-arm blood pressure index as a marker for atherosclerotic vascular diseases in hemodialysis patients. Am J Kidney Dis 1995;25:34-9.
5. Fowkes FG, Housley E, Cawood EH, et al. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20:384-92.
6. Newman AB, Tyrrell KS, Kuller LH. Mortality over four years in SHEP participants with a low ankle-arm index. J Am Geriatr Soc 1997;45:1472-8.
7. Leskinen Y, Salenius JP, Lehtimaki T, et al. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis 2002;40: 472-9.
8. Matsumae T, Abe Y, Murakami G, et al. Determinants of arterial wall stiffness and peripheral artery occlusive disease in nondiabetic hemodialysis patients. Hypertens Res 2007;30:377-85.
9. Ono K, Tsuchida A, Kawai H, et al. Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol 2003;14:1591-8.
10. Orchard TJ, Strandness DE Jr. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Heart Association and the American Diabetes Association 18-20 September 1992, New Orleans, Louisiana. Diabetes Care 1993;16:1199-209.
11. US Renal Data System. USRDS 2005 Annual Data Report. The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, MD, 2005.
12. Tomiyama H, Yamashina A, Arai T, et al. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement: a survey of 12517 subjects. Atherosclerosis 2003;166:303-9.
13. Yamashina A, Tomiyama H, Takeda K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002;25:359-64.
14. Yokoyama H, Shoji T, Kimoto E, et al. Pulse wave velocity in lower-limb arteries among diabetic patients with peripheral arterial disease. J Atheroscler Thromb 2003;10:253-8.
15. Dormandy JA, Rutherford RB. Management of peripheral artery disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31(Suppl 1):S1-44.
16. Gotch FA. Evolution of the single-pool urea kinetic model. Semin Dial 2001;14:252-6.
17. Fishbane A, Youn A, Flaster E, et al. Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients. Am J Kidney Dis 1996;27:668-72.
18. Testa A, Ottavioli JN. Ankle-arm blood pressure index (AABPI) in hemodialysis patients. Arch Mal Coeur Vaiss 1998;91:963-5. [In French]
19. de Vinuesa SG, Ortega M, Martinez P, et al. Subclinical peripheral arterial disease in patients with chronic kidney disease: prevalence and related risk factors. Kidney Int Suppl 2005:93:S44-7.
20. O'Hare AM, Glidden DV, Fox CS, et al. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2004;109:320-3.
21. Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000;58:353-62.
22. O'Hare AM, Hsu CY, Bacchetti P, et al. Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol 2002;13:497-503.
23. Jiang Y, Kohara K, Hiwada K. Association between risk factors for atherosclerosis and mechanical forces in carotid artery. Stroke 2000;31:2319-24.
24. Kensey KR, Cho YI, Chang M. Effects of whole blood viscosity on atherogenesis. J Invasive Cardiol 1997;9: 17-24.
25. Tous M, Ferre N, Vilella E, et al. Circulating blood cells modulate the atherosclerotic process in apolipoprotein E-deficient mice. Metabolism 2004;53:95-100.
26. Fowkes FG, Housley E, Riemersma RA, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992;135:331-40.
27. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979;241:2035-8.
28. Leavey SF, Strawderman RL, Jones CA, et al. Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 1998;31:997-1006.
29. Ridker PM, Cushman M, Stampfer MJ, et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97: 425-8.
30. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
31. Boaz M, Weinstein T, Matas Z, et al. Peripheral vascular disease and serum phosphorus in hemodialysis: a nested case-control study. Clin Nephrol 2005;63:98-105.
32. Grandaliano G, Teutonico A, Allegretti A, et al. The role of hyperparathyroidism, erythropoietin therapy, and CMV infection in the failure of arteriovenous fistula in hemodialysis. Kidney Int 2003;64:715-9.
33. Davies MR, Hruska KA. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int 2001; 60:472-9.
34. Deighan CJ, Caslake MJ, McConnell M, et al. Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation. Am J Kidney Dis 2000:35:852-62.
35. Nishizawa Y, Shoji T, Emoto M, et al. Roles of metabolic and endocrinological alterations in atherosclerosis and cardiovascular disease in renal failure: another form of metabolic syndrome. Semin Nephrol 2004;24:423-5.
36. Takenaka T, Kobayashi K, Suzuki H. Pulse wave velocity as an indicator of arteriosclerosis in hemodialysis patients. Atherosclerosis 2004;176:405-9.
37. Webb AT, Franks PJ, Reaveley DA, et al. Prevalence of intermittent claudication and risk factors for its development in patients on renal replacement therapy. Eur J Vasc Surg 1993;7:523-7.
38. Guerin AP, London GM, Marchais SJ, et al. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000;15:1014-21.